Cynthia Cortez
Nurse Practitioner · Bakersfield, CANPI 1942977038
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 327 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AbbVie at 27.3% of the total. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 327 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$430
- UCB, Inc.$397
- Biogen$378
- Lundbeck LLC$317
- Pfizer$300
- plus $3K from 27 others
What the payments were for
- Food & beverage$5,86899%
- Education$871%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 108 | $1,623 |
| Teva Pharmaceuticals USA, Inc. | 26 | $430 |
| UCB, Inc. | 20 | $397 |
| Biogen | 16 | $378 |
| Lundbeck LLC | 15 | $317 |
| Pfizer | 17 | $300 |
| AstraZeneca(2 entities) | 12 | $265 |
| Argenx US, Inc. | 11 | $245 |
| Eisai Inc. | 12 | $242 |
| Otsuka America Pharmaceutical, Inc. | 16 | $238 |
| Acadia Pharmaceuticals Inc | 9 | $192 |
| SK Life Science, Inc. | 5 | $136 |
| Sumitomo Pharma America, Inc. | 7 | $133 |
| EMD Serono, Inc. | 5 | $119 |
| Amneal Pharmaceuticals LLC | 6 | $101 |
| Novartis | 5 | $101 |
| Lilly USA, LLC | 6 | $96 |
| Genentech USA, Inc. | 3 | $78 |
| Acorda Therapeutics, Inc | 4 | $69 |
| TG Therapeutics, Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Averitas Pharma Inc. | 2 | $57 |
| Neurelis, Inc. | 3 | $49 |
| Amgen | 2 | $45 |
| Kyowa Kirin, Inc. | 3 | $45 |
| Medtronic | 1 | $26 |
| GE HealthCare | 1 | $26 |
| Tanabe Pharma America, Inc. | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
How this compares
$5,955 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 99 | $3,650 |
| Carbamazepine ErCarbamazepine | 13 | $2,763 |
| Levetiracetam | 39 | $2,098 |
| Pregabalin | 76 | $1,742 |
| Divalproex Sodium | 46 | $1,616 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 25 | $1,315 |
| Gabapentin | 60 | $821 |
| Quetiapine Fumarate | 36 | $705 |
| Ropinirole Hcl | 17 | $555 |
| Amitriptyline Hcl | 22 | $442 |
| Duloxetine Hcl | 14 | $420 |
| Propranolol Hcl | 11 | $420 |
| Donepezil Hcl | 26 | $318 |
| Topiramate | 12 | $194 |
| ClopidogrelClopidogrel Bisulfate | 17 | $98 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Bakersfield
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.